Ayala Pharmaceuticals logo
Ayala Pharmaceuticals AYLA

Geschäftsbericht 2022
hinzugefügt 31.03.2023

report update icon

Ayala Pharmaceuticals DSO 2011-2026 | AYLA

DSO Jährlich Ayala Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
61.7 35.4 67 - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
67 35.4 54.7

DSO Vierteljährlich Ayala Pharmaceuticals

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- 196 1.08 K 63.6 - 95 65.8 39.8 - 94.4 59.5 52.4 - 50.6 50.2 80.8 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
1.08 K 39.8 161

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
16.2 K $ 3.66 - $ 8.81 B australiaAustralia
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
16.8 - -13.39 % $ 1.45 M usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
2.47 - - $ 546 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
70.9 $ 21.46 0.47 % $ 1 B usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
6.83 - - $ 169 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
222 - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
61.7 - - $ 25.3 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
62.9 $ 1.49 1.35 % $ 383 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 3.03 3.77 % $ 4.99 M israelIsrael
Aquestive Therapeutics Aquestive Therapeutics
AQST
103 $ 4.19 - $ 448 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
106 $ 24.98 3.55 % $ 3.18 B usaUSA
Chimerix Chimerix
CMRX
588 - - $ 756 M usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
147 - - $ 401 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
321 $ 32.74 0.46 % $ 2.17 B usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
58.2 $ 1.48 0.46 % $ 394 M britainBritain
Cidara Therapeutics Cidara Therapeutics
CDTX
2.26 K - - $ 1.41 B usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
52.1 - - $ 1.2 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
13.6 - - $ 867 M germanyGermany